Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bb11fc5f69b5f246d66178e6dde691a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 |
filingDate |
2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d64d9d31ca2dc49a62252baed7f8741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33aac15735e4aad9ede6794425e3a963 |
publicationDate |
2018-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014239687-B2 |
titleOfInvention |
Transdermal drug delivery system containing rivastigmine |
abstract |
The present invention provides a transdermal drug delivery system, in the form of patch, comprising a drug-containing matrix layer comprising: (a) rivastigmine or a pharmaceutically acceptable salt thereof as an active ingredient; (b) an acrylate-hydrocarbon hybrid polymer as an adhesive and a selection of absorption enhancers. |
priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |